http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2008003873-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4423185f79003e8f9b981e29323454a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-04
filingDate 2008-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8300d9f34b32c04732aa798ed79e21a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41fe7ec830b453eecaa23d8b6a2a3d8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72d7e9e2cc68c298a7922924ea534c1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c78a09beffa4b693242baaba4f70cf2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48acd790478f06c097cef1cb252bbccb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adcb380325a9624f7eeee1847ad7390c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcaa20f3ac015d4a0f6ebd4d9a7c1f34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0d694122d24f1a5de00b84c5f834b61
publicationDate 2009-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CL-2008003873-A1
titleOfInvention Substituted benzofuropyrimidinone derivative compounds, protein kinase inhibitors; pharmaceutical composition comprising one of the compounds; method for inhibiting protein kinase in vitro (pim, cdc7, ck2); and use of the compounds in the preparation of drugs for the treatment of cancer
abstract Benzofuropyrimidinone derived compounds, protein kinase inhibitors; pharmaceutical composition, useful for the treatment of cancer such as pancreatic cancer, prostate cancer, leukemias and colorectal cancer.
priorityDate 2007-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420656275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67185623

Total number of triples: 28.